Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 711 | 2,713 | 4,449 | 5,621 | 3,949 |
| TOTAL | $1,765 | $3,699 | $4,721 | $5,929 | $4,177 |
| Non-Current Assets | |||||
| PPE Net | 315 | 343 | 370 | 398 | 426 |
| TOTAL | $315 | $343 | $370 | $398 | $426 |
| Total Assets | $2,079 | $4,042 | $5,092 | $6,327 | $4,603 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,346 | 1,857 | 718 | 983 | 635 |
| TOTAL | $1,346 | $1,857 | $718 | $983 | $635 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,346 | $1,857 | $718 | $983 | $635 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,792 | 3,805 | 3,802 | 3,140 | 2,896 |
| Retained earnings | -67,308 | -64,438 | -62,239 | -61,238 | -58,535 |
| TOTAL | $733 | $2,185 | $4,374 | $5,343 | $3,968 |
| Total Liabilities And Equity | $2,079 | $4,042 | $5,092 | $6,327 | $4,603 |